Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
49T0Bcz70HrQHxDF